Anheuser-Busch InBev SA/NV (BUD), the world's largest brewer and the maker of Budweiser, Corona, Stella Artois and Michelob Ultra, trades on the New York Stock Exchange as an American Depositary Receipt (ADR). After a strong run that has lifted the stock about 32% so far this year and placed it near its 52-week high, investors are asking how much further the shares can climb. This article examines whether BUD can reach a $95 stock price target and what would need to go right—or wrong—along the way.
The central $95 target is derived from recent, individually verified price targets rather than any single firm's call. Among clearly dated targets, Bank of America Securities stands at $111 (Buy, September 15, 2026), Evercore ISI at $105 (Buy, October 6, 2026), Wells Fargo at $88 (Buy, cut from $97 on October 5, 2026), TD Cowen at $85 (Hold, cut from $89 on October 13, 2026), and Morgan Stanley at $84.50 (lowered from $86.50 in July 2026). The arithmetic mean of these five is about $94.70, which rounds to $95 and sits in line with the broader 12-analyst average of roughly $95.26 reported by S&P Global.
The low-to-high spread—from about $84.50 to $111—illustrates that analysts disagree on how much credit to give the brewer's recovery. Bulls, such as Bank of America and Evercore ISI, emphasize margin recovery and a favorable demand backdrop. More cautious analysts, including Morgan Stanley and TD Cowen, point to currency translation drag and persistent volume softness in developed beer markets. Several firms have trimmed targets even while keeping Buy or Overweight ratings, a sign that the stock's rally has already absorbed part of the opportunity they previously saw.
At its latest verified close near $84.26, BUD trades just below its 52-week high of $86.60 and has a trailing P/E (price-to-earnings ratio) of roughly 18 and a dividend yield near 1.6%. Reaching $95 would require an advance of about 12.7%, a modest move relative to the stock's roughly 38% gain over the past year.
The path toward that level would most plausibly run through continued earnings growth and a clearing of the $86–$90 zone. The company's latest quarterly results, for the period ended June 30, 2026, showed revenue near $31.93 billion and net profit of about $6.31 billion, up sharply from roughly $3.35 billion a year earlier—evidence that pricing and cost discipline are flowing through to the bottom line. If that momentum persists, a grind toward $95 becomes more credible; if earnings growth stalls or the dollar strengthens further, the target would look harder to reach.
BUD has spent recent weeks consolidating between roughly $73 and $84 after a strong multi-month uptrend. The clearest resistance level is the 52-week high near $86.60, with $90 acting as a psychological barrier above it. On the downside, support appears in the $78–$80 zone, with a deeper shelf near $73–$75 from the early-October consolidation. A durable break above $86.60 would likely be required to build confidence in a move toward $95, while a failure to hold the $78–$80 area could signal fading momentum.
Analyst price targets typically reflect a roughly 12-month research horizon, and the targets used here are generally consistent with that convention, though individual firms do not always disclose identical periods. Investors should watch the company's next earnings report, scheduled around late October 2026, for updated volume, pricing, and margin guidance. Other items to track include currency movements, the pace of analyst target revisions, consumer-spending data in key beer markets, and any management commentary on World Cup-related demand.
For traders seeking a systematic edge, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying solely on long-term price targets, these signals help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently across fast-moving markets. Explore the AI Daily Buy/Sell Signals page to see how the tool can support your own monitoring process.
The central $95 target—the rounded mean of recent, individually attributed analyst price targets, and consistent with the broader ~$95.26 average reported across 12 analysts—would require a rise of about 12.7% from the latest price near $84.26. The case for getting there rests on margin recovery, resilient pricing, World Cup-related volume support, and a strong recent profit improvement. The case against it rests on currency headwinds, soft volumes, a stretched valuation after a long rally, and technical resistance near $86.60. With targets spanning roughly $84.50 to $111, analyst opinion is genuinely divided. Whether BUD reaches $95 will most likely depend on whether earnings momentum, rather than valuation expansion, drives the next leg of the rally. No outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, BUD has been loosely correlated with DEO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BUD jumps, then DEO could also see price increases.
| Ticker / NAME | Correlation To BUD | 1D Price Change % |
|---|---|---|
| BUD | 100% | -1.80% |
| BUD (1 stocks) | 64% Loosely correlated | -1.80% |
| Food: Meat/Fish/Dairy (7 stocks) | 54% Loosely correlated | -0.96% |